Logo
x

Search

Subscribe Now

Hematology

Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

  • March 2, 2021
Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics

Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics

  • February 11, 2021
BMS Signs an Exclusive Worldwide License Agreement with Dragonfly Therapeutics for DF6002

BMS Signs an Exclusive Worldwide License Agreement with Dragonfly Therapeutics for DF6002

  • August 17, 2020
Sobi Acquires Novimmune's Emapalumab with its All Related Assets to Strengthen its Focus in Hematology and Immunology

Sobi Acquires Novimmune's Emapalumab with its All Related Assets to Strengthen its Focus in Hematology and Immunology

  • June 13, 2019
Xoma Purchases Royalty Rights for Aronora's Five Preclinical and Clinical Hematology Candidates

Xoma Purchases Royalty Rights for Aronora's Five Preclinical and Clinical Hematology Candidates

  • April 8, 2019
Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio

Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio

  • February 6, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.